Hyasynth
Hyasynth is a biotech company in Montreal, Canada, founded in 2014. It has raised $5.0M across 5 rounds, most recently a $2.5M Corporate Round in January 2022.
Producing cannabinoids through yeast fermentation
- Headquarters
- Montreal
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- hyasynthbio.com
- Total Funding
- $5.0M
- Last Round
- $2.5M Corporate RoundJan 2022
- Rounds
- 5
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 5 funding rounds for this company. The full record is or through the API.
About
Hyasynth Bio is a Montreal-based biotechnology company that produces cannabinoids through yeast fermentation rather than traditional cannabis cultivation. Using a proprietary biosynthesis platform with genetically engineered yeast strains, the company manufactures pure CBD, THC, and other cannabinoids as ingredients for pharmaceutical, nutraceutical, and wellness applications. This fermentation-based approach enables consistent, scalable production without the agricultural inputs required by plant-based extraction.
Summary
It lists 11–50 employees. It has raised $5.0M in total across 5 rounds, most recently a $2.5M Corporate Round in Jan 2022.
Funding History
Jan 2022
Sign up to see all 5 events
Funding: Seed through Corporate Round. Amounts, valuations, and investors where available.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hyasynth"><img src="https://indexed.vc/api/badge/company/hyasynth" alt="Hyasynth on Indexed.vc" width="260" height="76" /></a>